Muenchener Rueckversicherungs-Gesellschaft in Muenchen News

Buy
Sell

Muenchener Rueckversicherungs-Gesellschaft in Muenchen News

Muenchener Rueckversicherungs-Gesellschaft in Muenchen News
YEARBuySell Net Total Trades
1.78 M EUR 11467,199.60 EUR 11.31 M EUR13
4.23 M EUR 2204.23 M EUR22
911,390.10 EUR 8781,241.00 EUR 2130,149.10 EUR11
1.25 M EUR 10670,794.20 EUR 3577,785.78 EUR13
1.45 M EUR 1101.45 M EUR11
920,078.70 EUR 80920,078.70 EUR8
Other

Kerner, Michael

Executive Board

298,500.00 EUR

500 × 597.00
Buy

Malherbe, Mari-Lizette

Executive Board

99,764.00 EUR

196 × 509.00
Buy

Buchanan, Andrew

Executive Board

152,700.00 EUR

300 × 509.00
Buy

Malherbe, Mari-Lizette

Executive Board

197,782.50 EUR

413 × 478.89
Buy

Buchanan, Andrew

Executive Board

172,728.00 EUR

370 × 466.83
Buy

Rieß, Dr. Markus

Executive Board

238,251.00 EUR

500 × 476.50
Buy

Golling, Stefan

Executive Board

199,999.50 EUR

419 × 476.19
Buy

Kassow, Dr. Achim

Executive Board

141,000.00 EUR

300 × 470.00
Buy

Malherbe, Mari-Lizette

Executive Board

199,282.20 EUR

377 × 528.60
Buy

Buchanan, Andrew

Executive Board

126,592.00 EUR

229 × 550.40
Sell

Haidegger-Rieß, Nathalie

in enger Beziehung

467,199.60 EUR

897 × 520.27
Buy

Malherbe, Mari-Lizette

Executive Board

197,752.00 EUR

379 × 520.40
Buy

Jäkel-Wickert, Julia Christiane

Supervisory Board

50,046.00 EUR

95 × 526.80
Buy

Jurecka, Dr. Christoph

Executive Board

325,560.00 EUR

600 × 542.60
Buy

Malherbe, Mari-Lizette

Executive Board

198,485.00 EUR

371 × 535.00
Buy

Jurecka, Dr. Christoph

Executive Board

311,880.00 EUR

600 × 519.80
Buy

Hervet ép. Kopff, Clarisse

Executive Board

42,510.00 EUR

78 × 545.00
Buy

Hervet ép. Kopff, Clarisse

Executive Board

923,775.00 EUR

1,695 × 545.00
Buy

Hervet ép. Kopff, Clarisse

Executive Board

3,270.00 EUR

6 × 545.00
Buy

Hervet ép. Kopff, Clarisse

Executive Board

11,445.00 EUR

21 × 545.00
Buy

Kerner, Michael

Executive Board

332,500.00 EUR

500 × 665.00
Buy

Malherbe, Mari-Lizette

Executive Board

184,151.56 EUR

327 × 563.15
Buy

Haidegger-Rieß, Nathalie

in enger Beziehung

199,800.00 EUR

360 × 555.00
Buy

Ossadnik, Dr. Victoria

Supervisory Board

302,628.80 EUR

529 × 571.00
Buy

Jurecka, Dr. Christoph

Executive Board

356,160.60 EUR

640 × 556.50
Buy

Jäkel-Wickert, Julia Christiane

Supervisory Board

50,130.00 EUR

90 × 557.00
Buy

Haidegger-Rieß, Nathalie

in enger Beziehung

198,690.00 EUR

358 × 555.00
Buy

Haidegger-Rieß, Nathalie

in enger Beziehung

100,188.00 EUR

180 × 556.60
Buy

Hervet ép. Kopff, Clarisse

Executive Board

103,382.40 EUR

193 × 532.90
Buy

Hervet ép. Kopff, Clarisse

Executive Board

166,786.00 EUR

313 × 532.86
Buy

Hervet ép. Kopff, Clarisse

Executive Board

18,122.00 EUR

34 × 533.00
Buy

Hervet ép. Kopff, Clarisse

Executive Board

66,067.20 EUR

124 × 532.80
Buy

Hervet ép. Kopff, Clarisse

Executive Board

35,704.20 EUR

66 × 532.90
Buy

Malherbe, Mari-Lizette

Executive Board

99,825.41 EUR

186 × 533.83
Buy

Malherbe, Mari-Lizette

Executive Board

196,308.00 EUR

410 × 478.80
Buy

Weidmann, Dr. Jens

Supervisory Board

51,860.00 EUR

100 × 518.60
Buy

Hervet ép. Kopff, Clarisse

Executive Board

26,790.00 EUR

57 × 470.00
Buy

Malherbe, Mari-Lizette

Executive Board

202,487.00 EUR

430 × 470.90
Buy

Jäkel-Wickert, Julia Christiane

Supervisory Board

49,822.50 EUR

105 × 474.50
Sell

Kassow, Dr. Achim

Executive Board

291,225.20 EUR

595 × 489.45
Other

Gartside, Nicholas

Executive Board

247,624.98 EUR

499 × 495.25
Sell

Rieß, Dr. Markus

Executive Board

490,015.80 EUR

999 × 490.02
Buy

Kerner, Michael

Executive Board

360,000.00 EUR

750 × 480.00
Buy

Jäkel-Wickert, Julia Christiane

Supervisory Board

50,358.00 EUR

110 × 457.80
Buy

Jurecka, Dr. Christoph

Executive Board

85,036.30 EUR

200 × 425.18
Buy

Jurecka, Dr. Christoph

Executive Board

85,036.30 EUR

200 × 425.18
Sell

Rieß, Dr. Markus

Executive Board

371,816.30 EUR

999 × 371.82
Buy

Kassow, Dr. Achim

Executive Board

49,950.00 EUR

135 × 370.00
Buy

Kerner, Michael

Executive Board

190,500.00 EUR

500 × 381.00
Buy

Kassow, Dr. Achim

Executive Board

52,185.00 EUR

150 × 347.90
Buy

Kassow, Dr. Achim

Executive Board

51,456.00 EUR

160 × 321.60
Buy

Gartside, Nicholas

Executive Board

149,699.98 EUR

499 × 299.40
Buy

Golling, Stefan

Executive Board

100,879.10 EUR

330 × 305.69
Buy

Häusler, Gerd Rolf

Supervisory Board

320,400.00 EUR

1,000 × 320.40
Sell

Rieß, Dr. Markus

Executive Board

241,575.90 EUR

750 × 322.10
Buy

Rieß, Dr. Markus

Executive Board

235,674.40 EUR

750 × 314.23
Buy

Kassow, Dr. Achim

Executive Board

48,251.50 EUR

155 × 311.30
Buy

Jurecka, Dr. Christoph

Executive Board

49,584.00 EUR

160 × 309.90
Sell

Blunck, Dr. Thomas

Executive Board

57,402.00 EUR

180 × 318.90
Buy

Kassow, Dr. Achim

Executive Board

54,694.80 EUR

200 × 273.47
Buy

Kassow, Dr. Achim

Executive Board

50,571.80 EUR

220 × 229.87
Buy

Rieß, Dr. Markus

Executive Board

66,420.00 EUR

300 × 221.40
Buy

Kassow, Dr. Achim

Executive Board

108,091.30 EUR

500 × 216.18
Buy

Jurecka, Dr. Christoph

Executive Board

64,590.00 EUR

300 × 215.30
Buy

Wenning, Dr. Joachim

Executive Board

44,940.00 EUR

210 × 214.00
Buy

Gartside, Nicholas

Executive Board

107,000.00 EUR

500 × 214.00
Buy

Golling, Stefan

Executive Board

302,520.00 EUR

1,200 × 252.10
Buy

Jurecka, Dr. Christoph

Executive Board

123,307.25 EUR

489 × 252.16
Buy

Jeworrek, Dr. Torsten

Executive Board

479,580.00 EUR

1,900 × 252.41
Buy

Kassow, Dr. Achim

Executive Board

50,533.40 EUR

199 × 252.67
Buy

Gartside, Nicholas

Executive Board

118,275.00 EUR

500 × 236.55
Buy

Gartside, Nicholas

Executive Board

189,900.00 EUR

750 × 253.20
Buy

Kassow, Dr. Achim

Executive Board

50,520.75 EUR

200 × 252.60
Buy

Kassow, Dr. Achim

Executive Board

50,064.00 EUR

210 × 238.40
Buy

Wenning, Dr. Joachim

Executive Board

249,583.66 EUR

1,104 × 225.87
Buy

Golling, Stefan

Executive Board

152,164.50 EUR

649 × 234.10
Buy

Gartside, Sophie

in enger Beziehung

58,912.49 EUR

249 × 235.65
Buy

Kassow, Dr. Achim

Executive Board

50,658.30 EUR

210 × 241.23

© Eulerpool Research Systems

Muenchener Rueckversicherungs-Gesellschaft in Muenchen Directors Dealings

In the last week, the Muenchener Rueckversicherungs-Gesellschaft in Muenchen stock was traded 0 times by insiders. The difference is 1.00 EUR.

In the last month, the Muenchener Rueckversicherungs-Gesellschaft in Muenchen stock was traded 1 times by insiders. The difference is 1.00 EUR.

In the last year, the Muenchener Rueckversicherungs-Gesellschaft in Muenchen stock was traded 16 times by insiders. The difference is 2,144,622.60 EUR.

Muenchener Rueckversicherungs-Gesellschaft in Muenchen Stock Analysis

MunichRe is a multinational insurance company that was founded in 1880 and is headquartered in Munich. Over the years, the company has expanded and established subsidiaries in Europe, Asia, and America. It operates in various sectors including catastrophe and accident insurance, life and health insurance, cybersecurity, and renewable energies. MunichRe's business model revolves around taking on the customer's risk and offering them a wide range of insurance options to minimize their financial risk. The company is known for its expertise in catastrophe insurance but has also faced criticism for potentially enabling irresponsible risk-taking. In addition to insurance services, MunichRe also provides consulting, risk analysis, claims management, and financial advisory services. The company emphasizes risk control and modeling to better understand potential losses and accurately capture financial information. MunichRe has developed a diverse portfolio of products and services to cater to different market needs, including disability insurance, fire insurance, health insurance, and private pension insurance. It also offers reinsurance services to help spread the risk among other insurance companies and contribute to stability and financial security in the insurance market. MunichRe positions itself as a pioneering force in the insurance industry and constantly seeks to innovate and renew its existing products. One such innovation is a new insurance model based on blockchain technology, aimed at providing secure and efficient contract processing in seconds. Overall, MunichRe is a major player in the global insurance market, offering a broad range of products and services. It continues to adapt to the challenges of the future, such as increasing digitization and interconnectedness, in order to provide the best services to its customers.

IssuerMuenchener Rueckversicherungs-Gesellschaft in Muenchen
Market capitalization- EUR
SymbolMUV2.DE
ISINDE0008430026
ISIN843002

7-day aggregated

30-day aggregated

365-day aggregated

2.14 M EUR

FAQ

The Basics on Insider Purchases

Profit with insiders.

Insider trades include both directors' dealings and insider sales. These insider transactions can serve as buying indicators for private investors, as they are based on insider information available to insiders. Directors' dealings are often referred to as directors' dealings. Eulerpool obtains the information directly from BaFin and the SEC.

Who is considered an insider?

An insider knows about non-publicly known circumstances surrounding publicly traded companies that can have a significant impact on the price - for example, because they have access to this insider information through their profession. Thus, insider information can be knowledge that a publicly traded company is about to undergo a capital measure or acquire a substantial stake. An insider is not necessarily a person with a professional connection to the issuer. An insider can also be close family members and persons living in the same household.

Legal Basis

Since July 1, 2002, pursuant to § 15a of the Securities Trading Act (WpHG), transactions in securities of their own company by members of the management board and supervisory board of listed companies and their family members must be promptly reported and published by the company. With the entry into force of the Investor Protection Improvement Act on October 30, 2004, the provisions of § 15a WpHG were significantly modified. With the applicability of the Market Abuse Regulation on July 3, 2016, the legal provisions on transactions by managerial personnel are regulated in Article 19 MAR. The publication of these transactions is an important contribution to the prevention of insider trading and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as they provide indications of the management's assessment of future business prospects.

Reporting obligations

According to Art. 19 MAR, executives must immediately report to the issuer and the competent authority any personal transaction involving shares or debt instruments of this issuer or related derivatives or other related financial instruments, no later than three business days after the transaction date. The reporting obligation also applies to spouses, registered life partners, dependent children, and other relatives who have been residing in the same household for at least one year. The same applies to legal entities closely related to the executive, trustees (e.g., foundations) or partnerships acting as trustees. Personal transactions are subject to reporting as soon as the total amount reaches EUR 5,000 by the end of the calendar year. With effect from 01.01.2020, BaFin has increased the threshold from EUR 5,000 to EUR 20,000 through a general ruling.

Publication obligations

The issuer is responsible for publishing reportable transactions within two business days after receiving a corresponding notification from the executive or a closely related person through appropriate media throughout the European Union. Additionally, the issuer is obligated to transmit the published information to the company registry, which stores it.

What are Directors Dealings?

Directors Dealings and insider sales can be summarized under the term insider trading. In English, the term Directors Dealings is commonly used.

These are purchases and sales of stocks by individuals who have insider information about the respective company.

But who is even considered an insider?

An insider is aware of non-publicly known circumstances surrounding publicly traded companies, which can have a significant impact on the price - for example, because they have obtained this insider information due to their profession.

An insider information can be the knowledge that a listed company is about to undertake a capital measure or acquire a significant stake.

An insider is not necessarily a person with a professional connection to the issuer. It can also refer to close family members and individuals residing in the same household.

Insider trading is prohibited.

It is important to understand that insider trading is prohibited.

A publicly traded company must disclose all information that could potentially affect the stock price as soon as possible. It is illegal for an insider to buy or sell shares based on this information that has not yet been disclosed.

So it should be clear that the published insider trades usually do not refer to trades that have a significant short-term impact on the stock price of a publicly traded company.

Rather, insider trades are about an insider's belief in a positive or negative future development of the company.

However, the normalization of (legal) insider trades does not mean that they cannot have an impact on the stock price.

Insider obligations

If you are a member of the executive board, the supervisory board, or a top-level executive of a publicly traded company and you buy or sell shares of your own company based on insider information, you must notify the company immediately (within 3 business days).

The company must then promptly (within 2 business days) disclose this information.

The same applies to family members of the mentioned individuals and other involved parties, such as legal entities closely associated with the insider, fiduciary institutions (e.g. foundations), or partnerships.

The reporting threshold has been set at 20,000 euros per calendar year since 2020 (previously 5,000 euros).

The mentioned information pertains to German companies.

How does the Eulerpool Directors Dealings Tool work?

With the Eulerpool Directors Dealings Tool, you can easily find out which Directors Dealings are available at German companies in the last 7, 30, or 365 days occurred. Directors Dealings of shares from the USA will be added in the near future.

In principle, you have two options to use the Directors Dealings Tool:
  • Search for directors dealings of a specific stock within the timeframe of 7, 30, or 365 days.
  • Search for all directors dealings in the period of 7, 30, or 365 days.

Option 1: Search for directors dealings of a specific stock.

If you want to check whether there has been any insider trading activity for a particular stock recently, you can search for it using the stock's name or the stock's ISIN.

Option 2: Search for all directors dealings

If you want to know which Directors Dealings have occurred in all German stock companies recently, Eulerpool's Directors Dealings Tool can also help you.

Simply call up the page and select the desired time period, and you will immediately see all Directors Dealings in the table. But how do you read the table?

So how to read the table

The table consists of the following 6 columns:
  • Issuer
  • ISIN
  • Purchase volume
  • Sales volume
  • Number
  • Difference

Issuer/ISIN

With the names (issuer) and ISIN, you can uniquely identify a stock. By clicking on both parameters, you will get more information about insider trading for the selected stock. But more on that later.

Purchase and Sales Volume

When looking at the buying and selling volume, you can see how much volume of stocks has been traded in insider trades. For example, if a stock is worth 100 euros and an insider buys it 100 times, you will see a value of 10,000 euros in the buying volume column. If an insider has sold stocks for the same amount, you will see the 10,000 euros in the selling volume.

Difference

The difference is calculated by the buying and selling volume. If an insider trading transaction involves buying a volume of 100,000 euros, but only selling 50,000 euros, you will see a green value of 50,000 euros in the difference. In the case of a negative difference, you will see a red number with a minus sign in front. This indicates that more shares were sold than bought in insider trades.

Number

The number indicates how much insider trading has occurred at the respective company. Both purchases and sales are included here.

Sort table

Now you know how to read the table. However, if you use option 2, you still need to sort the results. At Eulerpool's Directors Dealings Tool, you can sort all columns from top to bottom (or vice versa).

If you click on, for example, "purchase volume", the results will be sorted in descending order based on purchase volume as the leading criterion. If you click on it again, the sorting will change from descending to ascending.

The same is also possible with all other columns. Every time you click on the respective column, it will become the leading criterion for sorting the results.

You can customize the results for insider trading according to your preferences. If you have found a stock that is noticeable to you, for example, due to a high number of directors dealings or a significant difference, you naturally want to gather more information. As mentioned briefly before, the Directors Dealings Tool from Eulerpool also assists you with that.

Further information about insider trading

By clicking on issuer or ISIN, you will be directed to a page with further information about the company. In addition to the business model and stock price of the company, you can see how much insider trading has occurred in the last 7, 30, and 365 days (number, difference).

As a special highlight, you can see in the table notifications who exactly made the insider trade. In addition to the obligated party, you can see the volume of the trade, the insider's position (including close relationship, executive board), the stock price at the time of the trade, the number of shares traded, and the date of the trade. This way, you can track all directors dealings in detail.

Now you can start further research and find out with qualitative information what exactly led to the insider trade.

Where does the data on insider trading come from?

Finally, the answer to an important question. We obtain the data from the Eulerpool Directors Dealings Tool directly from the Federal Financial Supervisory Authority (BaFin).

For the Directors Dealings of stocks from the USA, we will rely on data from the United States Securities and Exchange Commission (SEC) in the future.

We are also providing the Equity Screening with the highest possible data quality.

Why insider trading is prohibited and how you as an investor can still benefit from it.

In the section "What are Directors Dealings?" we have informed, among other things, about the duties of insiders. But why does insider trading actually have to be reported?

Insider trading can influence the price.

To repeat: In the case of publicly traded companies, any information that could affect the stock price must be disclosed. This is clear to everyone when it comes to Quarterly results and the like. However, directors' dealings can also influence a stock price.

Let's imagine that the CEO of a company, which has reported excellent numbers recently, suddenly sells a larger portion of his own stocks. If you are invested in this company, the CEO's stock sale would definitely be relevant information for you. Perhaps the sale is an indicator of weaker future performance or other deficiencies within the company. After all, if the CEO doesn't have the best information about the company, then who does?

If the CEO were not required to disclose his sale, you will understand why (undisclosed) insider trading is prohibited. The CEO has eliminated an unfair advantage by having access to privileged information compared to the investors.

Of course, it is also prohibited and even illegal if, for example, the CEO buys or sells stocks based on ad-hoc mandatory information. If he knows, for example, about an impending bankruptcy that is not yet publicly known, he is not allowed to sell any stocks.

Basically, in Germany, insider trading is also prohibited during the publication of Quarterly results and during the period of the initial public offering (IPO).

In summary, it can be said that without these mechanisms, the functioning of the capital market would be at risk.

You can benefit from insider trading.

Since insider trading must be disclosed, as a private investor you can benefit from it.

However, it is important to note that a decision for or against a stock should never be based solely on insider trading. Ultimately, only the pure fact of the purchase or sale is initially at stake. The reasons behind it will only be known later, or in many cases, not at all.

It should also be considered that executives are often biased towards their own company. Accordingly, they may perceive the future of the company more positively than it actually is and buy stocks of the company based on this perception. In such cases, there are no insider information available. It is also possible that executives may intentionally purchase stocks in order to positively influence the company's stock price.

Who is the insider?

Another important question when evaluating an insider trade is: Who is the insider in the first place? In general, the following can be stated: The higher-ranking the insider, the more relevant the insider trading. The reason for this is logical, as a higher-ranking person will generally have the best information.

Assessing directors dealings and sales differently

To conclude this chapter, we want to highlight an important point from our perspective. Namely, that purchases and sales should not be considered equivalent.

Directors' dealings are a (slightly) positive indicator.

We can ask ourselves the simple question of why we buy a stock. The answer is in 99.9% of cases, because we want to achieve a positive return. And likely, executives also buy stocks for the same reason in the majority of cases.

As mentioned in the previous section, there may not necessarily be groundbreaking insider information here.

However, an insider purchase can still be a (strongly) positive indicator. But only if the insider buys the stocks with their own money. On the other hand, stocks or options packages as part of compensation are not a positive indicator, as no conscious decision is made for the company in this case.

Even more positive is to see a company where there have been several purchases by one person or purchases by multiple persons recently. In such a company, a more in-depth analysis is recommended. You can find these companies using Eulerpool's Directors Dealings Tool.

Insider sales are a (strong) negative indicator.

There can be many reasons why an investor sells stocks. However, investors should be cautious when larger sell-offs by board members or institutional investors occur. This type of selling signal can indicate problems or uncertainties within the company and may cause the stock price to fall. It is advisable to closely monitor such sales and analyze the background before making a selling decision yourself. When it comes to sales, it is important to keep a cool head and not act purely out of panic. Instead of selling blindly, you should engage with the facts, make an informed decision, and possibly seek the opinion of a financial advisor.

But when it comes to insider sales, it is probably worth taking a closer look than with directors dealings. Especially when the company is actually doing well externally.

It is also important to know how many own shares the insider sold. At 5%, it is naturally less relevant than at 50%.

If a CEO, for example, sells, then one should definitely take a closer look.

Always assess the context.

But here too, the same applies. Without a context, It is difficult to assess the whole. This becomes clear with an example from the recent past.

Elon Musk has sold billions of dollars' worth of shares as CEO of Tesla. Without context, this headline would likely imply a (strongly) negative impact on Tesla's stock. However, since the sale was made to finance the acquisition of Twitter, the sale can be seen in a different (more positive) light.

We do not want to make a statement about the sense or nonsense of these measures, but rather illustrate how strongly the context categorizes insider trading.

What does science say about insider trading?

To conclude the article, we would like to briefly discuss what science says about insider trading. Because insider trades have already been examined in a variety of scientific studies.

In general, it can be stated that insider trades can provide information about future returns. In this regard, directors' dealings on average have a greater positive impact on the stock price than insider sales have a negative impact on it.

The science also confirms that insider trades by higher-ranking individuals have a greater impact on the stock price.

Also just logical. The larger the trade, the more relevant. The more people make the trade, the more relevant.

Finally, however, there is one new piece of information from science for this article. It has been found that insider trades have a greater impact on the price of smaller companies than on larger ones.

Further scientific information can be found, for example, at 2iQ Research and The Evidence-Based Investor.